# KALA BIO, Inc.: Form SCHEDULE 13D/A, filed Oct 1, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-01
- Accepted by EDGAR: Oct 1, 2025, 19:31 ET
- Period: not reported
- Accession: 0001193125-25-227218
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000119312525227218/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000119312525227218/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000119312525227218/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-227218. Last ingested by Listed: Nov 9, 2026, 18:14 ET. No prices; not investment advice.